- Home
- RGNX vs WNC Comparison
RGNX vs WNC Comparison
Compare RGNX & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | WNC |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 392.2M |
| IPO Year | 2015 | 2009 |
Fundamental Metrics
Financial Performance| Metric | RGNX | WNC |
|---|---|---|
| Price | $8.61 | $8.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $28.75 | $11.00 |
| AVG Volume (30 Days) | ★ 752.0K | 439.0K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | 18.08 | ★ 179.22 |
| EPS | N/A | ★ 5.07 |
| Revenue | $10,393,000.00 | ★ $2,027,489,000.00 |
| Revenue This Year | $50.05 | $0.53 |
| Revenue Next Year | $23.31 | $25.53 |
| P/E Ratio | ★ N/A | $1.70 |
| Revenue Growth | ★ 126.48 | 8.81 |
| 52 Week Low | $5.04 | $6.78 |
| 52 Week High | $16.19 | $12.94 |
Technical Indicators
Market Signals| Indicator | RGNX | WNC |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 44.44 |
| Support Level | $7.81 | $8.58 |
| Resistance Level | $9.28 | $9.39 |
| Average True Range (ATR) | 0.48 | 0.39 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 67.76 | 65.07 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.